Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany
CANNANNEW REPORT

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021. Dr. Reddy’s will be the exclusive distributor of several of MediCane’s medical cannabis products in Germany. Additionally, Dr. Reddy’s and MediCane have entered into a collaboration and co-funding arrangement relating to a phase II clinical trial for a medicinal cannabis product aimed at symptom relief of Behavioral and Psychological Symptoms of Dementia (BPSD). When launched, Dr. Reddy’s holds exclusive sales and marketing rights for the product in Europe (except Russia and CIS countries). AUGSBURG, Germany & VANCOUVER, British Columbia & HYDERABAD, India–(BUSINESS WIRE)–#Agreement–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) and MediCane Health Inc. (along with its subsidiaries together referred to as “MediCane”) today announced the launch of its medical cannabis product in Germany. As part of a collaboration between Dr. Reddy’s and MediCane that started in 2021, MediCane will supply the medical cannabis products to Dr. Reddy’s from its EU-GMP-certified facilities in Portugal along with providing logistical and regulatory support. As the exclusive distributor of the products in Germany, Dr. Reddy’s will provide access to MediCane’s medical cannabis products under its own brand supported by a specialized field force that can provide education on the use of the products and guidance on the health insurance reimbursement process to healthcare professionals. The launch marks MediCane’s entry into the pharmaceutical sector of a major European market. For Dr. Reddy’s, the launch reinforces its presence in Germany’s growing medical cannabis market, building on its recent acquisition of Nimbus Health GmbH that specializes in the distribution, registration, sales and marketing of medical cannabis. With over 83 million inhabitants benefitting from broad access to healthcare services, Germany already represents more than half of…

Excerpt only …
READ MORE BELOW
Source : Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.